Cost Analysis of End-Stage Renal Disease in Pediatric Patients in Greece
Open Access
- 18 October 2024
- journal article
- research article
- Published by MDPI AG in Healthcare
- Vol. 12 (20) , 2074
Abstract
Background/Objectives: The cost resulting from peritoneal dialysis (PD), conventional hemodialysis (HD) and online hemodiafiltration (OL-HDF) in pediatric patients with end-stage renal disease (ESRD) has not been estimated to date in Greece. The present single-center retrospective study aimed to estimate the mean annual cost of the above methods, as well as the individual components of this cost. Methods: Twenty pediatric patients undergoing the three different methods of renal replacement therapy were included in this study. Their mean total annual cost was estimated by the method of micro-costing and the bottom-up approach. Results: The mean total annual cost for PD patients (n = 7) was estimated at EUR 56,676.04; for conventional HD patients (n = 9), it was EUR 39,786.86; and for OL-HDF patients (n = 4), it was EUR 43,894.73. The PD method was found to be more expensive than the other two methods (p < 0.001 vs. conventional HD and p = 0.024 vs. OL-HDF). PD consumables used for daily application had the greatest contribution to the total annual cost. The total mean annual cost in the groups of patients undergoing HD and OL-HDF did not differ significantly (p = 0.175). The total operating cost of the renal dialysis unit had the greatest contribution to the total mean annual costs of both the conventional HD and OL-HDF techniques. Conclusions: This cost analysis provides useful information to healthcare policymakers who make decisions about the treatment of children with ESRD.Keywords
This publication has 30 references indexed in Scilit:
- Development of PD in lower-income countries: a rational solution for the management of AKI and ESKDKidney International, 2024
- US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United StatesAmerican Journal of Kidney Diseases, 2019
- Factors associated with high-cost hospitalization for peritonitis in children receiving chronic peritoneal dialysis in the United StatesPediatric Nephrology, 2019
- Global overview of health systems oversight and financing for kidney careKidney International Supplements, 2018
- Cost analysis of substitutive renal therapies in childrenJornal de Pediatria, 2018
- Chronic dialysis in children and adolescents: challenges and outcomesThe Lancet Child & Adolescent Health, 2017
- Economic evaluation of hemodialysis: Implications for technology assessment in GreeceInternational Journal of Technology Assessment in Health Care, 2005
- A prospective cohort study of incident maintenance dialysis in children: An NAPRTC study11The North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) is a voluntary collaborative effort comprising over 150 pediatric renal disease treatment centers in the United States, Canada, Mexico and Costa Rica. It is supported by major, unrestricted educational grants from Novartis, AMGEN, and Genentech. Participating NAPRTCS Centers are listed in the most recent NAPRTCS Annual Report [Seikaly M, Ho PL, Emmet L, Tejani A: The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS): Renal Transplantation from 1987 through 1998. Pediatr Transplant 5:215–231, 2001].Kidney International, 2003
- Chronic dialysis in children and adolescents. The 2001 NAPRTCS Annual ReportPediatric Nephrology, 2002
- An economic evaluation of hospital-based hemodialysis and home-based peritoneal dialysis for pediatric patientsAmerican Journal of Kidney Diseases, 1996